Table 1.
Expression of HIF-1α protein in three groups
Time | Group | HIF-1α protein levels
|
P-value
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
0 | 1+ | 2+ | 3+ | 4+ | All three groups | Group 1 vs group 2 | Group 1 vs group 3 | Group 2 vs group 3 | ||
6 hours | 1 (n=6) | 3 | 2 | 1 | ||||||
2 (n=6) | 1 | 3 | 2 | 0.003 | 0.004 | 0.665 | 0.004 | |||
3 (n=6) | 2 | 3 | 1 | |||||||
24 hours | 1 (n=6) | 3 | 2 | 1 | ||||||
2 (n=6) | 4 | 2 | 0.002 | 0.003 | 0.652 | 0.003 | ||||
3 (n=6) | 1 | 4 | 1 | |||||||
3 days | 1 (n=6) | 4 | 1 | 1 | ||||||
2 (n=6) | 1 | 4 | 1 | 0.003 | 0.004 | 0.652 | 0.004 | |||
3 (n=6) | 3 | 2 | 1 |
Notes: Group 1 means control group, group 2 means TAE-treated group, and group 3 means liposomal curcumin TAE-treated group. P, statistical comparison between groups.
Abbreviations: HIF-1α, hypoxia-inducible factor-1α; TAE, transcatheter arterial embolization.